Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-12 Sale | 2024-02-12 8:22 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 2,573 | $11.44 | $29,435 | 451,449 (Direct) | View |
| 2024-02-12 Sale | 2024-02-12 8:21 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 1,173 | $11.44 | $13,419 | 643,277 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:15 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 1,585 | $11.54 | $18,291 | 336,728 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:14 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer | 3,310 | $11.54 | $38,197 | 352,473 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:13 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 11,552 | $11.54 | $133,310 | 836,950 (Direct) | View |
| 2024-02-02 Sale | 2024-02-05 7:12 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 8,669 | $11.54 | $100,040 | 529,022 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-13 5:24 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director | 17,000 | $9.879 | $167,943 | 144,389 (Direct) | View |
| 2023-11-13 Purchase | 2023-11-13 5:24 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 5,000 | $10.29 | $51,448 | 254,800 (Direct) | View |
| 2023-10-04 Sale | 2023-10-06 7:19 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer | 10,628 | $19.5 | $207,298 | 105,685 (Direct) | View |
| 2023-10-04 Sale | 2023-10-06 7:19 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 6,068 | $19.5 | $118,355 | 874,439 (Indirect Direct) | View |
| 2023-10-04 Sale | 2023-10-06 7:18 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 5,482 | $19.5 | $106,926 | 387,691 (Direct) | View |
| 2023-09-11 Sale | 2023-09-13 4:11 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director | 5,000 | $25.05 | $125,238 | 47,970 (Direct) | View |
| 2023-06-20 Purchase | 2023-06-20 4:30 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 4,760,000 | $22.66 | $107,861,600 | 13,959,973 (Indirect) | View |
| 2023-05-31 Sale | 2023-05-31 9:10 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 27,768 | $26.27 | $729,506 | 463,502 (Direct) | View |
| 2023-05-26 Sale | 2023-05-31 9:09 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 80,000 | $30.02 | $2,401,248 | 880,507 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-14 7:10 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 7,851 | $20.13 | $158,005 | 392,048 (Direct) | View |
| 2023-02-13 Sale | 2023-02-14 7:09 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 11,833 | $20.09 | $237,760 | 491,270 (Direct) | View |
| 2023-02-13 Sale | 2023-02-14 7:07 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 10,307 | $20.14 | $207,629 | 960,507 (Indirect Direct) | View |
| 2023-02-06 Sale | 2023-02-06 7:36 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 10,000 | $22.27 | $222,678 | 503,103 (Direct) | View |
| 2023-01-17 Sale | 2023-01-18 5:15 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 10,000 | $24.15 | $241,515 | 352,011 (Direct) | View |
| 2023-01-05 Sale | 2023-01-05 7:16 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 10,000 | $21.02 | $210,228 | 362,011 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-04-11 07:02 am | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Vultaggio Vincent Principal Accounting Officer | 0 | $0 | 110,083 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:16 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | HAUSMAN DIANA Chief Medical Officer | 337,500 | $0 | 714,732 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:15 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 141,000 | $0 | 336,728 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:14 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea Chief Legal Officer | 202,500 | $0 | 352,473 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:13 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 192,500 | $0 | 836,950 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:12 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 75,000 | $0 | 529,022 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-05 7:11 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 20,655 | $11.69 | 734,145 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 7:11 pm | N/A 2034-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 250,000 | $0 | 734,145 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-03 8:21 pm | N/A 2034-01-02 | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 100,000 | $0 | 116,313 (Direct) | View |
Ownership | 2024-01-03 8:19 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Lackner Mark Chief Scientific Officer | 0 | $0 | 255,000 (Direct) | View |
| 2023-12-20 Gift | 2023-12-21 5:47 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 24,158 | $0 | 850,281 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-16 5:04 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director | 19,059 | $0 | 127,389 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-16 5:02 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director | 16,364 | $0 | 38,181 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-16 5:01 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director | 16,364 | $0 | 52,970 (Direct) | View |
| 2023-05-08 Option Award | 2023-05-10 07:13 am | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | HAUSMAN DIANA Director | 39,732 | $0 | 39,732 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 4:30 pm | N/A 2033-03-01 | Zentalis Pharmaceuticals Inc. | ZNTL | Roth Iris Chief Operating Officer | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:09 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 224,000 | $0 | 1,103,460 (Direct) | View |
| 2022-11-09 Gift | 2023-02-01 7:09 pm | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Scientific Officer | 30,000 | $0 | 1,103,460 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:08 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President | 395,000 | $0 | 747,011 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:08 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Chief Executive Officer | 600,000 | $0 | 605,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:07 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer | 250,000 | $0 | 547,942 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:06 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Paul Andrea General Counsel | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-01 7:06 pm | N/A 2033-01-31 | Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer | 40,000 | $0 | 140,000 (Direct) | View |